Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy [Phase 3]
Phase 3 clinical trial update evaluating effectiveness and safety of Filgrastine in patients with breast cancer undergoing myelotoxic chemot…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System [NA]
A completed clinical trial evaluating opto-acoustic image quality using the Gen 2 Imagio system for breast cancer conditions; results posted…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel [Phase 3]
Phase 3 trial evaluating Neugranin in breast cancer patients receiving doxorubicin/docetaxel for chemotherapy-induced neutropenia has comple…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Pamidronate Administration in Breast Cancer Patients With Bone Metastases [Phase 4]
Phase 4 clinical trial update on pamidronate administration in breast cancer patients with bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating adjuvant paclitaxel and trastuzumab for node-negative HER2-positive breast cancer has completed with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy [Phase 3]
A Phase 3 trial evaluating aspirin to prevent recurrence in node-positive HER2-negative breast cancer after standard therapy was terminated;…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. [Phase 3]
A Phase 3 trial update for HOBOE evaluating adjuvant triptorelin with tamoxifen, letrozole, or letrozole plus zoledronic acid in premenopaus…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating Vinorelbine, Carboplatin, and Trastuzumab (VinCaT) in advanced HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating neratinib with or without fulvestrant in HER2-positive, estrogen receptor-positive metastatic breast cancer has b…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy
A completed clinical trial presenting patient characteristics, treatment patterns, and clinical outcomes for HR+/HER2-negative advanced/meta…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer [Phase 1, Phase 2]
Clinical trial update for TQB3909 tablets in advanced breast cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer [Phase 2, Phase 3]
A study evaluating MRG002 for HER2-positive unresectable locally advanced or metastatic breast cancer spanning Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: UK Ibrance Patient Program (IPP) Study
Clinical trial update for the UK Ibrance Patient Program (IPP) study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging [Phase 2, Phase 3]
Clinical trial update for contrast-enhanced Cone Beam Breast CT in breast cancer under Phase 2 and Phase 3, currently terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Efficacy of Cilostazol in Prevention of Peripheral Neuropathy [Phase 1, Phase 2]
A clinical trial update evaluates cilostazol for prevention of peripheral neuropathy in patients with breast cancer, spanning Phase 1 and Ph…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer [Phase 2]
Phase 2 trial evaluating whether adding trastuzumab to chemotherapy improves outcomes in stage II or III breast cancer; results posted 2023-…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer [Phase 2]
Phase 2 clinical trial of tamoxifen citrate in metastatic or recurrent breast cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant [Phase 2]
A Phase 2 trial evaluating palbociclib in combination with an aromatase inhibitor or fulvestrant in women with advanced breast cancer has co…
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: Effectiveness of Combined Erector Spinae and Pecto-intercostal Fascial Plane Blocks Versus Thoracic Paravertebral Block in Perioperative Pain in Modified Radical Mastectomy [Phase 4]
Phase 4 trial evaluating the effectiveness of combined erector spinae and pecto-intercostal fascial plane blocks versus thoracic paravertebr…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer) [Phase 2]
This clinical trial update reports on a Phase 2 study comparing giredestrant with physician's choice of endocrine therapy in previously trea…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant [Phase 3]
Phase 3 trial comparing fulvestrant alone versus fulvestrant plus palbociclib in operable breast cancer responding to fulvestrant has comple…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial exploring pre-surgical treatment with carboplatin and an albumin-stabilized nanoparticle formulation of paclitaxel in patien…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer [Phase 3]
Phase 3 trial evaluating neoadjuvant hormonal therapy plus palbociclib in operable, hormone receptor–positive, HER2-negative breast cancer h…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer [Phase 1]
Phase 1 clinical trial update for giredestrant (GDC-9545) in postmenopausal women with operable stage I-III estrogen receptor-positive breas…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer Survivors [NA]
A completed clinical trial evaluating a remotely delivered physical activity intervention for breast cancer survivors; results posted in 202…